245 related articles for article (PubMed ID: 33746041)
1. Loss of Camk2n1 aggravates cardiac remodeling and malignant ventricular arrhythmia after myocardial infarction in mice via NLRP3 inflammasome activation.
Wei Z; Fei Y; Wang Q; Hou J; Cai X; Yang Y; Chen T; Xu Q; Wang Y; Li YG
Free Radic Biol Med; 2021 May; 167():243-257. PubMed ID: 33746041
[TBL] [Abstract][Full Text] [Related]
2. Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca
Suetomi T; Willeford A; Brand CS; Cho Y; Ross RS; Miyamoto S; Brown JH
Circulation; 2018 Nov; 138(22):2530-2544. PubMed ID: 30571348
[TBL] [Abstract][Full Text] [Related]
3. Sacubitril/valsartan (LCZ696) reduces myocardial injury following myocardial infarction by inhibiting NLRP3‑induced pyroptosis via the TAK1/JNK signaling pathway.
Shen J; Fan Z; Sun G; Qi G
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34296299
[TBL] [Abstract][Full Text] [Related]
4. Activation in M1 but not M2 Macrophages Contributes to Cardiac Remodeling after Myocardial Infarction in Rats: a Critical Role of the Calcium Sensing Receptor/NRLP3 Inflammasome.
Liu W; Zhang X; Zhao M; Zhang X; Chi J; Liu Y; Lin F; Fu Y; Ma D; Yin X
Cell Physiol Biochem; 2015; 35(6):2483-500. PubMed ID: 25967877
[TBL] [Abstract][Full Text] [Related]
5. Exacerbated post-infarct pathological myocardial remodelling in diabetes is associated with impaired autophagy and aggravated NLRP3 inflammasome activation.
Mao S; Chen P; Pan W; Gao L; Zhang M
ESC Heart Fail; 2022 Feb; 9(1):303-317. PubMed ID: 34964299
[TBL] [Abstract][Full Text] [Related]
6. CircHelz activates NLRP3 inflammasome to promote myocardial injury by sponging miR-133a-3p in mouse ischemic heart.
Bian Y; Pang P; Li X; Yu S; Wang X; Liu K; Ju J; Wu H; Gao Y; Liu Q; Jia Y; Qu Z; Bi X; Mei Z; Yin X; Wang N; Du W; Yang B
J Mol Cell Cardiol; 2021 Sep; 158():128-139. PubMed ID: 34043986
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Dectin-1 in mice ameliorates cardiac remodeling by suppressing NF-κB/NLRP3 signaling after myocardial infarction.
Li X; Bian Y; Pang P; Yu S; Wang X; Gao Y; Liu K; Liu Q; Yuan Y; Du W
Int Immunopharmacol; 2020 Mar; 80():106116. PubMed ID: 31978804
[TBL] [Abstract][Full Text] [Related]
8. Calhex231 ameliorates myocardial fibrosis post myocardial infarction in rats through the autophagy-NLRP3 inflammasome pathway in macrophages.
Liu W; Sun J; Guo Y; Liu N; Ding X; Zhang X; Chi J; Kang N; Liu Y; Yin X
J Cell Mol Med; 2020 Nov; 24(22):13440-13453. PubMed ID: 33043596
[TBL] [Abstract][Full Text] [Related]
9. Muscone attenuates susceptibility to ventricular arrhythmia by inhibiting NLRP3 inflammasome activation in rats after myocardial infarction.
Yang S; Bi Y; Wei Y; Li W; Liu J; Mao T; Tang Y
J Biochem Mol Toxicol; 2023 Nov; 37(11):e23458. PubMed ID: 37455625
[TBL] [Abstract][Full Text] [Related]
10. Cathelicidin aggravates myocardial ischemia/reperfusion injury via activating TLR4 signaling and P2X
Wu Y; Zhang Y; Zhang J; Zhai T; Hu J; Luo H; Zhou H; Zhang Q; Zhou Z; Liu F
J Mol Cell Cardiol; 2020 Feb; 139():75-86. PubMed ID: 31982429
[TBL] [Abstract][Full Text] [Related]
11. TXNIP aggravates cardiac fibrosis and dysfunction after myocardial infarction in mice by enhancing the TGFB1/Smad3 pathway and promoting NLRP3 inflammasome activation.
Zhang Y; Wang J; Wang X; Li A; Lei Z; Li D; Xing D; Zhang Y; Su W; Jiao X
Acta Biochim Biophys Sin (Shanghai); 2023 Dec; 55(12):1950-1960. PubMed ID: 37850269
[TBL] [Abstract][Full Text] [Related]
12. Phloretin ameliorates heart function after myocardial infarction via NLRP3/Caspase-1/IL-1β signaling.
Li B; Xu L; Liu J; Zhou M; Jiang X
Biomed Pharmacother; 2023 Sep; 165():115083. PubMed ID: 37413902
[TBL] [Abstract][Full Text] [Related]
13. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury.
Sandanger Ø; Ranheim T; Vinge LE; Bliksøen M; Alfsnes K; Finsen AV; Dahl CP; Askevold ET; Florholmen G; Christensen G; Fitzgerald KA; Lien E; Valen G; Espevik T; Aukrust P; Yndestad A
Cardiovasc Res; 2013 Jul; 99(1):164-74. PubMed ID: 23580606
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation.
Yao C; Veleva T; Scott L; Cao S; Li L; Chen G; Jeyabal P; Pan X; Alsina KM; Abu-Taha I; Ghezelbash S; Reynolds CL; Shen YH; LeMaire SA; Schmitz W; Müller FU; El-Armouche A; Tony Eissa N; Beeton C; Nattel S; Wehrens XHT; Dobrev D; Li N
Circulation; 2018 Nov; 138(20):2227-2242. PubMed ID: 29802206
[TBL] [Abstract][Full Text] [Related]
15. The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction.
Gao R; Shi H; Chang S; Gao Y; Li X; Lv C; Yang H; Xiang H; Yang J; Xu L; Tang Y
Int Immunopharmacol; 2019 Sep; 74():105575. PubMed ID: 31299609
[TBL] [Abstract][Full Text] [Related]
16. Glycogen synthase kinase-3β inhibition alleviates activation of the NLRP3 inflammasome in myocardial infarction.
Wang S; Su X; Xu L; Chang C; Yao Y; Komal S; Cha X; Zang M; Ouyang X; Zhang L; Han S
J Mol Cell Cardiol; 2020 Dec; 149():82-94. PubMed ID: 32991876
[TBL] [Abstract][Full Text] [Related]
17. CLEC5A knockdown protects against cardiac dysfunction after myocardial infarction by suppressing macrophage polarization, NLRP3 inflammasome activation, and pyroptosis.
Wang X; Hu Y; Wang Y; Shen D; Tao G
Biochem Cell Biol; 2021 Oct; 99(5):655-665. PubMed ID: 33939927
[TBL] [Abstract][Full Text] [Related]
18. Role of NLRP3 Inflammasome in Cardiac Inflammation and Remodeling after Myocardial Infarction.
Takahashi M
Biol Pharm Bull; 2019; 42(4):518-523. PubMed ID: 30930410
[TBL] [Abstract][Full Text] [Related]
19. Electroacupuncture preconditioning attenuates acute myocardial ischemia injury through inhibiting NLRP3 inflammasome activation in mice.
Zhang T; Yang WX; Wang YL; Yuan J; Qian Y; Sun QM; Yu ML; Fu SP; Xu B; Lu SF
Life Sci; 2020 May; 248():117451. PubMed ID: 32088213
[TBL] [Abstract][Full Text] [Related]
20. P2X
Yin J; Wang Y; Hu H; Li X; Xue M; Cheng W; Wang Y; Li X; Yang N; Shi Y; Yan S
J Cell Mol Med; 2017 Nov; 21(11):2695-2710. PubMed ID: 28470940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
